{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:45:22Z","timestamp":1770540322320,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"crossref","award":["26860119"],"award-info":[{"award-number":["26860119"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.xphs.2016.12.021","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T18:19:00Z","timestamp":1483640340000},"page":"1175-1182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Adjuvant-Induced Inflammation on Disposition of Diclofenac and Its Metabolites in Perfused Rat Liver"],"prefix":"10.1016","volume":"106","author":[{"given":"Misato","family":"Uraki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Sayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2016.12.021_bib1","first-page":"545","article-title":"Diclofenac sodium","volume":"8","author":"Small","year":"1989","journal-title":"Clin Pharm"},{"key":"10.1016\/j.xphs.2016.12.021_bib2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.1840220320","article-title":"Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions","volume":"22","author":"Banks","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.xphs.2016.12.021_bib3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.102.038992","article-title":"Extrapolation of diclofenac clearance from in\u00a0vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide","volume":"303","author":"Kumar","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2016.12.021_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/toxsci\/61.1.49","article-title":"Characterization of rat and human UDP-glucuronosyltransferases responsible for the in\u00a0vitro glucuronidation of diclofenac","volume":"61","author":"King","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.xphs.2016.12.021_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0022-3565(24)38933-5","article-title":"Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats","volume":"295","author":"Xiong","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2016.12.021_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.106.101840","article-title":"Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat","volume":"319","author":"Zamek-Gliszczynski","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2016.12.021_bib7","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.107.015107","article-title":"Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease","volume":"35","author":"Lickteig","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/hep.20898","article-title":"Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene","volume":"42","author":"Manautou","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.xphs.2016.12.021_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0041-008X(03)00368-5","article-title":"Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity","volume":"192","author":"Boelsterli","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.xphs.2016.12.021_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1389200033489398","article-title":"The metabolism of diclofenac-enzymology and toxicology perspectives","volume":"4","author":"Tang","year":"2003","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.xphs.2016.12.021_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1021\/tx9802217","article-title":"Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac","volume":"12","author":"Tang","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.xphs.2016.12.021_bib12","first-page":"1608","article-title":"Bioactivation of diclofenac via benzoquinone imine intermediates-identification of urinary mercapturic acid derivatives in rats and humans","volume":"29","author":"Poon","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/dmd.104.003095","article-title":"Detection of a novel reactive metabolite of diclofenac: evidence for CYP2C9-mediated bioactivation via arene oxides","volume":"33","author":"Yan","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1472-8206.1989.tb00667.x","article-title":"Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat","volume":"3","author":"Belpaire","year":"1989","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.xphs.2016.12.021_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02028122","article-title":"Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats","volume":"37","author":"Piquette-Miller","year":"1992","journal-title":"Agents Actions"},{"key":"10.1016\/j.xphs.2016.12.021_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1023\/A:1018907431893","article-title":"Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay","volume":"10","author":"Piquette-Miller","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.12.021_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/chir.530060508","article-title":"Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat","volume":"6","author":"Laethem","year":"1994","journal-title":"Chirality"},{"key":"10.1016\/j.xphs.2016.12.021_bib18","first-page":"42","article-title":"Rheumatoid factors: historical perspective, origins and possible role in disease","volume":"32","author":"Williams","year":"1992","journal-title":"J\u00a0Rheumatol Suppl"},{"key":"10.1016\/j.xphs.2016.12.021_bib19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1248\/bpb.16.1130","article-title":"Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states","volume":"16","author":"Shibata","year":"1993","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.xphs.2016.12.021_bib20","first-page":"253","article-title":"Prolonged pentobarbital sleeping time in adjuvant-induced polyarthritic rats","volume":"9","author":"Dipasquale","year":"1974","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.xphs.2016.12.021_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/00498254.2012.710350","article-title":"Alteration in plasma protein binding properties of propranolol and flurbiprofen during development of adjuvant-induced arthritis in rats","volume":"43","author":"Kawase","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2016.12.021_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/chir.10227","article-title":"Stereoselective pharmacokinetics of flurbiprofen and formation of covalent adducts with plasma protein in adjuvant-induced arthritic rats","volume":"15","author":"Nagao","year":"2003","journal-title":"Chirality"},{"key":"10.1016\/j.xphs.2016.12.021_bib23","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1002\/jps.24210","article-title":"Decreased radixin function for ATP-binding cassette transporters in liver in adjuvant-induced arthritis rats","volume":"103","author":"Kawase","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2016.12.021_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13318-015-0259-4","article-title":"Effects of dose, flow rate, and bile acid on diclofenac disposition in the perfused rat liver","volume":"41","author":"Uraki","year":"2016","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.xphs.2016.12.021_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/00498259409043263","article-title":"Effect of adjuvant-induced arthritis on hepatic drug metabolism in rats","volume":"24","author":"Toda","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2016.12.021_bib26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1023\/A:1018996018708","article-title":"Glucuronidation kinetics of R,S-ketoprofen in adjuvant-induced arthritic rats","volume":"16","author":"Meunier","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.12.021_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11095-004-9010-6","article-title":"Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain","volume":"22","author":"Projean","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.12.021_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0090-9556(24)14879-9","article-title":"Glucuronidation of R- and S-ketoprofen, acetaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats","volume":"27","author":"Christine","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/00498250801935982","article-title":"Prediction of metabolic clearance of diclofenac in adjuvant-induced arthritis rats using a substrate depletion assay","volume":"38","author":"Uno","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2016.12.021_bib30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1124\/dmd.110.037622","article-title":"Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport","volume":"39","author":"Kindla","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1023\/B:PHAM.0000026420.79421.8f","article-title":"The complexities of hepatic drug transport: current knowledge and emerging concepts","volume":"21","author":"Chandra","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.12.021_bib32","doi-asserted-by":"crossref","first-page":"37161","DOI":"10.1074\/jbc.274.52.37161","article-title":"A\u00a0novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters","volume":"274","author":"Hsiang","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2016.12.021_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/gast.2001.21176","article-title":"Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver","volume":"120","author":"Kullak-Ublick","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xphs.2016.12.021_bib34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00210-006-0040-y","article-title":"Pharmacogenomics of human OATP transporters","volume":"372","author":"Konig","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.xphs.2016.12.021_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/dmd.113.054783","article-title":"Utility of Oatp1a\/1b-knockout and OATP1B1\/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein","volume":"42","author":"Higgins","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/dmd.115.066944","article-title":"Diclofenac and its acyl glucuronide: determination of in\u00a0vivo exposure in human subjects and characterization as human drug transporter substrates in\u00a0vitro","volume":"44","author":"Zhang","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0090-9556(24)14912-4","article-title":"Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites","volume":"27","author":"Tang","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib38","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1124\/dmd.31.11.1327","article-title":"Studies on the chemical reactivity of diclofenac acyl glucuronide with glutathione: identification of diclofenac-S-acyl-glutathione in rat bile","volume":"31","author":"Grillo","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib39","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1021\/tx034038b","article-title":"Mechanistic studies on the bioactivation of diclofenac: identification of diclofenac-S-acyl-glutathione in\u00a0vitro in incubations with rat and human hepatocytes","volume":"16","author":"Grillo","year":"2003","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.xphs.2016.12.021_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2125.1990.tb03613.x","article-title":"Biliary elimination of non-steroidal anti-inflammatory drugs in patients","volume":"29","author":"Schneider","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xphs.2016.12.021_bib41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/00498257909042327","article-title":"Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites","volume":"9","author":"Stierlin","year":"1979","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2016.12.021_bib42","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.2042-7158.1996.tb03961.x","article-title":"Inhibitory effect of pentobarbital on biliary excretion of diclofenac in a rat liver perfusion system","volume":"48","author":"Fukuyama","year":"1996","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2016.12.021_bib43","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/0049825021000012664","article-title":"Decreased activity of hepatic P-glycoprotein in the isolated perfused liver of the adjuvant arthritis rat","volume":"32","author":"Achira","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2016.12.021_bib44","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/0049825021000017939","article-title":"Decreased hepatobiliary transport of methotrexate in adjuvant arthritis rats","volume":"32","author":"Achira","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2016.12.021_bib45","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/jps.24043","article-title":"Distinct alterations in ATP-binding cassette transporter expression in liver, kidney, small intestine, and brain in adjuvant-induced arthritic rats","volume":"103","author":"Kawase","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2016.12.021_bib46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2002.31871","article-title":"Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats","volume":"35","author":"Masubuchi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.xphs.2016.12.021_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00210-006-0062-5","article-title":"The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis","volume":"373","author":"Cai","year":"2006","journal-title":"Naunyn-schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.xphs.2016.12.021_bib48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib49","doi-asserted-by":"crossref","first-page":"31185","DOI":"10.1074\/jbc.M110.107805","article-title":"Regulation of MRP2\/ABCC2 and BSEP\/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-\u03b1, IL-6, and IL-1\u03b2","volume":"285","author":"Diao","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2016.12.021_bib50","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1124\/dmd.30.9.962","article-title":"Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment","volume":"30","author":"Xiong","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2016.12.021_bib51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1440-1746.2004.03275.x","article-title":"Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats","volume":"19","author":"Kuroda","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.xphs.2016.12.021_bib52","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/hep.510290404","article-title":"Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane","volume":"29","author":"Konig","year":"1999","journal-title":"Hepatology"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916419477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916419477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T01:25:47Z","timestamp":1749864347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916419477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0022354916419477"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.12.021","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Adjuvant-Induced Inflammation on Disposition of Diclofenac and Its Metabolites in Perfused Rat Liver","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}